Chemical Compound

DAUNORUBICIN CITRATE

CAS Registry Number 371770-68-2
DAUNORUBICIN CITRATE chemical structure
Primary Record

DAUNORUBICIN CITRATE

In stock
4,668 g
Purity
99.5 %
CAS
371770-68-2

Compound Identifiers & Properties

CAS
371770-68-2
PubChem CID
9961878
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O

Names & Synonyms

  • DAUNORUBICIN CITRATE
  • DaunoXome
  • Daunorubicin liposomal
  • DaunoXome (TN)
  • Daunomycin(citrate)
  • Daunorubicin (citrate)
  • Daunorubicin citrate liposome
  • UNII-5L84T2Z6NP
  • RefChem:54933
  • Daunorubicin citrate [MART.]
  • 5L84T2Z6NP
  • SCHEMBL42311
  • Daunorubicin citrate [Orange Book]
  • Daunorubicin citrate (MART.)
  • DTXSID20190659
  • orb1983522
  • CHEMBL1200475
  • SCHEMBL29354629
  • DTXCID10113150
  • BADC-01360
  • DAUNORUBICIN CITRATE [WHO-DD]
  • 371770-68-2
  • CID9961878
  • CID 9961878
  • HY-108876
  • CS-0031208
  • DAUNORUBICIN CITRATE LIPOSOME [VANDF]
  • D10787
  • Q27262517
  • (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;2-hydroxypropane-1,2,3-tricarboxylic acid
  • 1884557-85-0
  • 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
  • 2-Hydroxypropane-1,2,3-tricarboxylic acid--(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1/1)
  • 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
  • 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1) (SALT)